English | 简体中文 | 繁體中文 | 한국어
Share:
Galapagos increases share capital through warrant exercises

Mechelen, Belgium; 20 March 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises.

Galapagos issued 149,370 new ordinary shares on 20 March 2019, for a total capital increase (including issuance premium) of €3,480,747.50.

Pursuant to the warrant exercise program of Galapagos' executive committee, executive committee members automatically are committed to exercise a minimum number of warrants, subject to certain conditions. In accordance with the rules of this program, CEO Onno van de Stolpe exercised 15,000 warrants. Three other executive committee members exercised an aggregate number of 50,000 warrants. In addition to Onno van de Stolpe, two other members of our board of directors exercised an aggregate number of 11,280 warrants.

In accordance with Belgian transparency legislation[1], Galapagos notes that its total share capital currently amounts to €295,407,803.81, the total number of securities conferring voting rights is  54,614,791, which is also the total number of voting rights (the "denominator"), and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights is 4,467,412 which equals the total number of voting rights that may result from the exercise of these warrants. Galapagos does not have any convertible bonds or shares without voting rights outstanding.

About Galapagos

Galapagos (Euronext & NASDAQ: GLPG) discovers and develops small molecule medicines with novel modes of action, three of which show promising patient results and are currently in late-stage development in multiple diseases. Our pipeline comprises Phase 3 through to discovery programs in inflammation, fibrosis, osteoarthritis and other indications. Our ambition is to become a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines. More information at www.glpg.com.

Contacts

Investors:

Elizabeth Goodwin

VP Investor Relations

+1 781 460 1784

Sofie Van Gijsel

Director IR

+32 485 19 14 15

[email protected]

Media:

Carmen Vroonen

Senior Director Communications & Public Affairs

+32 473 824 874

Evelyn Fox

Director Communications

+31 6 53 591 999

[email protected]

Forward-looking statements

This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.



[1]     Belgian Act of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted to trading on a regulated market





This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Galapagos NV via Globenewswire

Copyright © Thomson Reuters 2019. All rights reserved.
Press Releases
FLSmidth wins contract for new cement plant in Morocco  
June 20, 2019 09:00 ET
FRO - Acquisition of VLCC Resale and Two LR2 Newbuildings  
June 19, 2019 22:07 ET
Eastman to Acquire INACSA  
June 19, 2019 20:29 ET
Ahold Delhaize issues its first Sustainability Bond  
June 19, 2019 18:00 ET
Sompo International to Leverage AIR's Innovative Casualty Analytics Solution for Multi-Line Risk Analysis  
June 19, 2019 16:59 ET
Eastman to Acquire INACSA  
June 19, 2019 14:00 ET
SDLP - Changes to Management and the Board of Directors  
June 19, 2019 12:03 ET
Lubrizol Announces Global Collaboration with Corbion  
June 18, 2019 15:29 ET
Verisk Financial Helps Neobank Xinja Ensure APRA Compliance  
June 4, 2019 22:29 ET
Curt Espeland to address the Deutsche Bank Global Industrials & Materials Summit  
May 30, 2019 22:29 ET
More News >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: